An accompanying conference call to discuss results will be held at 10:00 a.m. EST, on March 20.
Bacterin International develops, manufactures and markets biologics products.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
